| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/06/1996 | EP0699669A1 Triazole derivative or salt thereof, and fungicide containing the same |
| 03/06/1996 | EP0699208A1 Novel peptide nucleic acids |
| 03/06/1996 | EP0699203A1 Thiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides |
| 03/06/1996 | EP0699202A1 Calanolide and related antiviral compounds, compositions, and uses thereof |
| 03/06/1996 | EP0699201A1 SUBSTITUTED METHYLENEDIOXY 3',4':6,7]INDOLIZINO- 1,2-$i(b)]QUINOLINONES |
| 03/06/1996 | EP0699195A1 Thioindole pyperidinyl derivatives used as antalgics |
| 03/06/1996 | EP0699187A1 DERIVATIVES OF -g(b), -g(b)-DIMETHYL-4-PIPERIDINEETHANAMINE AS INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS |
| 03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
| 03/06/1996 | EP0699076A1 Otitis media vaccine |
| 03/06/1996 | EP0699071A1 Anti-viral guanosine-rich oligonucleotides |
| 03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
| 03/06/1996 | CN1118142A Combinations of retroviral inhibitors |
| 03/06/1996 | CN1118140A Oligonucleotides modified to improve stability at ACID pH |
| 03/06/1996 | CN1118138A Substituted azolone derivatives for treating diseases caused by helicobacter |
| 03/06/1996 | CN1118137A Method of reversing resistance of HIV-1 strains to zidovudine |
| 03/06/1996 | CN1117965A Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines |
| 03/06/1996 | CN1117863A Chailian oral liquor |
| 03/06/1996 | CN1031193C Polypeptide and method for preparing same |
| 03/06/1996 | CN1031190C Process for preparation of quinoline carboxylic acid derivatives |
| 03/05/1996 | US5496947 Quinolone carboxylic acid derivatives |
| 03/05/1996 | US5496816 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 03/05/1996 | US5496727 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 03/05/1996 | US5496706 Methods and materials for the detection of Staphylococcus aureus |
| 03/05/1996 | US5496564 Suspendible composition and process for preparing the same |
| 03/05/1996 | CA2043129C Antiviral glove |
| 03/03/1996 | CA2155705A1 Cephalosporin derivatives |
| 02/29/1996 | WO1996006177A2 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
| 02/29/1996 | WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | WO1996006103A2 α-D-PENTOFURANOSIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND THEIR USE |
| 02/29/1996 | WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| 02/29/1996 | WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists |
| 02/29/1996 | WO1996006069A1 D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof |
| 02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996001614A3 Rna component of telomerase |
| 02/29/1996 | CA2198384A1 Alpa-d-pentofuranoside derivatives, process for preparing the same and their use |
| 02/29/1996 | CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2197650A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
| 02/28/1996 | EP0698347A2 Food composition containing reuterin |
| 02/28/1996 | EP0698116A1 Processes for producing an enzyme |
| 02/28/1996 | EP0698113A1 Production of toxin binding biopolymers, use thereof |
| 02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
| 02/28/1996 | EP0698042A1 Composition of antibodies against hepatitis b surface antigen |
| 02/28/1996 | EP0698027A1 Deoxythiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides |
| 02/28/1996 | EP0698019A1 Novel aromatic nitro compounds and their metabolites useful as anti-viral and anti-tumor agents |
| 02/28/1996 | EP0698015A1 Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole |
| 02/28/1996 | EP0698012A1 Novel deoxygalactonojirimycin derivatives |
| 02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
| 02/28/1996 | EP0697879A1 Cyclohexapeptidyl aminoalkyl ethers |
| 02/28/1996 | EP0697876A1 Xenograft thymus |
| 02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 02/28/1996 | EP0697864A1 Treatment of septic shock |
| 02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
| 02/28/1996 | CN1117743A Method to predict active growth of bacteria adhered to a surface |
| 02/28/1996 | CN1117742A Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 02/28/1996 | CN1117492A Treatment of H. pylori infections |
| 02/28/1996 | CN1117491A 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative |
| 02/28/1996 | CN1117383A Cefixime composition |
| 02/27/1996 | US5495032 Process for producing 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 02/27/1996 | US5495031 Process for the production of 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 02/27/1996 | US5495030 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines |
| 02/27/1996 | US5495020 Chemical intermediate for bactericides, microbiocides, disinfectants; side effect reduction, absorption |
| 02/27/1996 | US5495018 7-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 02/27/1996 | US5494932 Aids, retroviruses, herpes viruses, cytomegalovirus |
| 02/27/1996 | US5494931 Anticoccidial in poultry, preventing and treating swine dysentery, growth promoter in cattle and swine |
| 02/27/1996 | US5494916 Imidazo[4,5-C]pyridin-4-amines |
| 02/27/1996 | US5494809 Culturing and incubating cells of bacillus amyloliquefaciens |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/27/1996 | US5494666 Beta-lactamase inhibitors, antibacterials |
| 02/27/1996 | US5494661 Froom a croton species, administering in vivo to humans or animals |
| 02/27/1996 | CA1338085C Antibiotics bu-3608d and bu-3608e from actinomadura |
| 02/27/1996 | CA1338083C Ozonides of terpenes and their medical uses |
| 02/22/1996 | WO1996005294A1 Method for preparing an influenza virus, antigens obtained and applications thereof |
| 02/22/1996 | WO1996005288A2 T cell activation |
| 02/22/1996 | WO1996005229A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 02/22/1996 | WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it |
| 02/22/1996 | WO1996005211A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
| 02/22/1996 | WO1996005209A2 Sialic acid/fucose based medicaments |
| 02/22/1996 | WO1996005196A1 Distamycin a analogues as antitumour or antiviral agents |
| 02/22/1996 | WO1996005187A1 (4-(3-aminomethylphenyl)thiazol-2-yl)-guanidines as h2-receptor antagonists |
| 02/22/1996 | WO1996004929A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 02/22/1996 | WO1996004923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | WO1996004913A1 Hiv protease inhibitor combination |
| 02/22/1996 | WO1996004907A1 Pharmaceutical formulation |
| 02/22/1996 | WO1996004788A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | WO1996004787A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | WO1996001110A3 Anti-hiv triple combination |
| 02/22/1996 | WO1996000068A3 Combination therapy for hiv infection |
| 02/22/1996 | CA2197801A1 T cell activation |
| 02/22/1996 | CA2197336A1 Sialic acid/fucose based medicaments |
| 02/22/1996 | CA2197205A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | CA2197117A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | CA2196203A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | CA2172629A1 Distamycin a analogues as antitumour or antiviral agents |